# Evaluating the Use of Magnetic Resonance Imaging and Contrast Enhanced Mammography After MagTrace® Use

> **NCT05637528** · — · UNKNOWN · sponsor: **Zuyderland Medisch Centrum** · enrollment: 25 (estimated)

## Conditions studied

- Breast Cancer

## Interventions

- **DIAGNOSTIC_TEST:** MRI

## Key facts

- **NCT ID:** NCT05637528
- **Lead sponsor:** Zuyderland Medisch Centrum
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-11-23
- **Primary completion:** 2023-02-23
- **Final completion:** 2023-03-31
- **Target enrollment:** 25 (ESTIMATED)
- **Last updated:** 2022-12-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05637528

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05637528, "Evaluating the Use of Magnetic Resonance Imaging and Contrast Enhanced Mammography After MagTrace® Use". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05637528. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*